Haben Biologika einen Stellenwert bei Kollagenosen? Contra

Biologika - Kollagenosen

biologicals - collagenoses

Literatur

• 1 [The legal aspects of „off label use” or: Doubtful private prescription].  Internist . 2008;  49 322-327
• 2 Carson K R, Evens A M, Richey E A, Habermann T M, Focosi D, Seymour J F. et al . Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.  Blood. 2009;  113 4834-4840
• 3 Harris H E. Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab.  Rheumatology (Oxford). 2008;  47 224-225
• 4 Ramos-Casals M, Brito-Zeron P, Munoz S, Soto M J. A systematic review of the off-label use of biological therapies in systemic autoimmune diseases.  Medicine (Baltimore). 2008;  87 345-364